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Summary We have studied a remarkable family with seven cases of malignant lymphoma extending through
three generations wherein five sisters and their mother had histopathologically documented non-Hodgkin's
lymphoma, while a granddaughter had Hodgkin's disease. An immunological study of three lymphoma
survivors, nine of their first degree relatives, and four spouse controls was undertaken. Significant findings
consisted of a depressed serum IgG3 level in four of the nine first-degree relatives; in two of these four,
lymphocyte stimulation by both pokeweed mitogen and concanavalin A were significantly depressed. The
subtle immunological abnormalities present in this kindred may be associated with the pathogenesis of the
lymphomas.
Familial clustering of non-Hodgkin's lymphoma (NHL) and
Hodgkin's disease (HD) has been reported in concert with
clinical or laboratory evidence of immunodeficiency in
affected and in their non-affected primary and secondary
relatives (Green, 1982; Purtilo et al., 1982; Seemanova et al.,
1985; Anderson et al., 1986; Clark et al., 1987). Geographic
clustering of NHL (Weisenburger, 1985; Barnes et al., 1987)
and HD (Vianna et al., 1973; Vianna & Polan, 1973;
Schwartz et al., 1978) also has been recognised.
Our purpose is to describe genetic, laboratory and
pathology findings on an extraordinary family with seven
female members affected by lymphoma through three
generations. The family is indigenous to a rural area in the
Platte river valley of Nebraska where an excess incidence of
lymphoma has been identified (Weisenburger, 1985).
Materials and methods
Ascertainment
This Caucasian family was ascertained through an inquiry
from a key NHL-affected relative (III-5 in Figure 1) who
was concerned about the excess of lymphoma in her family.
Interviews and questionnaires enabled a detailed survey of
this proband and all of her primary relatives in the search
for information about cancer of all anatomic sites,
environmental exposures when known, and vital medical and
demographic information. Permission forms allowed us to
secure primary medical and pathology information. Selected
relatives were examined, at which time peripheral blood was
obtained for laboratory studies.
Pathology evaluation and lymphoma immunophenotyping
Microscopic glass slides, paraffin tissue blocks (when
available) and pathology reports were obtained from the
primary hospital laboratories. Hematoxylin and eosin-stained
histological sections of lymphomas from biopsy and autopsy
tissues were evaluated by two pathologists (J.N.M. and
D.D.W.) and histologically classified by the Rappaport
system and the Working Formulation (The Non-Hodgkin's
Lymphoma Pathologic Classification Project, 1982). In the
two cases where fresh tissue was available, the lymphomas
were phenotyped with monoclonal antibodies against B and
T lymphocyte differentiation antigens (Coulter Immunology,
Hialeah, FL, USA; Beckton-Dickenson, Sunnyvale, CA,
USA), using the avidin-biotin complex (ABC) immuno-
peroxidase technique (Hsu et al., 1981).
Correspondence: H.T. Lynch.
Laboratory studies
At the time of testing, two surviving affecteds, ten unaffected
first degree relatives (including one who six months later
developed lymphoma), one second degree relative and four
spouse controls were available for laboratory evaluation.
Sera were tested by standard techniques for the presence of
Coombs antibody, rheumatoid factor, antinuclear antibodies
and antibodies to Epstein-Barr virus (EBV), viral capsid
antigens (VCA), early antigens (EA) and EBV-associated
nuclear antigens (EBNA). Immunoglobulins were
quantitated by nephelometry (IgA, IgM) or radial immuno-
diffusion (IgG subclasses) (ICN ImmunoBiologicals, Lisle,
IL, USA). Peripheral blood lymphocyte subsets were
enumerated on an EPICS 541 flow cytometer, using a whole-
blood lysis procedure and fluorescein or phycoerythrin
direct-labelled monoclonal antibodies against T cells (Ti1
against the CD2 antigen), helper T lymphocytes (T4 against
CD4 antigen), suppressor/cytotoxic T lymphocytes (T8
against CD8 antigen), natural killer cells (NKHI) and B
lymphocytes (BI against CD20 antigen; Coulter
Immunology). To assess proliferative responses, peripheral
blood mononuclear cells were isolated on a discontinuous
density gradient (Boyum, 1968), and stimulated with PHA
(Wellcome Labs, Research Triangle Park, NC, USA),
pokeweed mitogen (PWM) (Sigma Chemical Company, St
Louis, MO, USA), and concanavalin A (Maluish & Strong,
1986). Uptake of tritiated thymidine was counted in
triplicate wells in a scintillation counter, and net mean
counts per minute were derived by subtraction of mean
background counts. For each assay cells from a laboratory
donor known to respond normally were included. Natural
killer (NK) cell function was measured using a standard
radioactive chromium release assay with K562 target cells
(Pross et al., 1986). Phenotyping for human leukocyte
antigens (HLA) was performed by the NIH method of
microlymphocytotoxicity.
Results
The pedigree (Figure 1) and Tables I and II display the
cancer occurrences, pathology and immunopathology
findings in this informative kindred. All seven of the
malignant lymphomas occurred in women. Their ages ranged
from 36 to 71 years (mean 54 years) at the times of diagnosis
(Table I). The time relationship of development of
lymphoma among the affected family members ranged from
1957 for individual 111-9 to 1987 for patient 111-7, who was
the most recently affected with non-Hodgkin's lymphoma.
The non-Hodgkin's lymphomas showed ages of onset
ranging from 39 to 64 for the five sisters (111-1, 111-5, III-7,
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Figure 1 Pedigree of family showing lymphoma in seven relatives through three generations.
Table I Clinical and pathologic characteristics of the lymphoma
Site
R. adnexa,
mesentery
52 R. submaxillary
gland node
56 Cervical lymph
node
64 Base of tongue
39 R. axillary
57 L. supraclavicular
lymph node
62 L. cervical
lymph node
36 R. cervical
lymph node
Working Rappaport
Stage formulation classification
IIIB Diffuse mixed Diffuse, mixed
lymphocytic and
histiocytic
? Follicular Nodular mixed
mixed lymphocytic and
histiocytic
? Follicular
mixeda
Ia Diffuse
mixeda
IVB Diffuse mixed
IB Follicular
mixed
(progressing
IVB to diffused
mixed)
I? Hodgkin's
nodular
sclerosing
aImmunophenotyped as B cell lymphomas (see text).
Nodular mixed
lymphocytic and
histiocytic
Diffuse mixed
lymphocytic and
histiocytic
Diffuse mixed,
lymphocytic and
histiocytic
Nodular mixed
lymphocytic and
histiocytic
(progressing
to diffuse
mixed lymphocytic
and histiocytic)
Hodgkin's
nodular
sclerosing
III-9, III-1 1), in the years 1966, 1984, 1987, 1957 and 1978,
respectively. In addition, the brother of one, a fraternal twin
(111-3 in Figure 1), developed adenocarcinoma of the
gastro-esophageal junction at age 63. All of the affected
patients lived or grew up near St Paul, Nebraska, a rural
farming community in the Platte river valley.
The results of laboratory testing are shown in Table II,
along with normal ranges. At the time of testing, the
obligate gene carrier (111-7) had not yet manifested her
lymphoma, and is, thus, classified as a first degree at risk
relative in the table.
The pathology findings are briefly summarised in Table I,
which provides lymphoma diagnoses in the Rappaport
classification and the Working Formulation (the Non-
Hodgkin's Lymphoma Pathologic Classification Project,
1982). Four of the six non-Hodgkin's lymphoma cases were
probably of B cell origin. This was evidenced by the
follicular pattern of architecture in three of the cases (III-1,
111-5, 111-1 1), one of which (111-5) immunophenotyped
positive for B-associated antigens CDlO and Ba-2, and
monotypic mu heavy and lambda light immunoglobulin
chains on frozen tumour tissue which was available. Frozen
tissue was also available on an additional case, 111-7 (diffuse
mixed cell type), which immunophenotyped for B-associated
antigens CD19, CD20 and CD22, with monotypic mu and
kappa surface immunoglobulin chain expression.
Unfortunately, except for these two cases, neither frozen nor
paraffin block tumour tissue was available for further
immunophenotype study.
The lymphocyte enumerations, expressed as absolute
counts, were within normal ranges except for subject 111-5.
These low T and B cell values are probably due to the
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Age at
diagnosis
71
Pedigree
no.
11-8
111-1
111-5
111-7
111-9
111-11
IV-10
Status
Dead, 7 years
Dead, 2 years
Alive, 3+years
Alive, 0.5 years
Dead, 1 year
Dead, 5 years
Alive, 5 years
mftA rDnA624 H.T. LYNCH et al.
Table II Immunological laboratory findings
Tll T4 T8 T4/T8 NKHJ BJ IgGI IgG2 IgG3 IgG4 IgA IgM PHA PWM ConA NK
Normal
Min. 600 400 150 >0.7 80 50 422 117 41 0 70 56
Max. 2,800 1,900 900 500 450 1,292 717 129 291 312 352
Lymphoma cases
III-5a 260 80 70 1.1 80 30 560 201 18 8 160 37 44 44 44 N
IV_10b 980 410 440 0.9 180 450 592 81 60 2 128 104 N 4 N N
Primary relatives
IV-8 2,000 780 750 1.0 310 180 854 449 41 38 311 80 ND ND ND N
IV-11 1,790 840 490 1.7 110 200 641 220 47 20 235 158 N N N N
IV-9 2,410 1,040 630 1.6 270 260 534 174 51 11 104 58 N N N N
IV-12 1,250 720 230 3.1 90 90 698 192 21 36 190 201 N N N N
IV-7 1,890 780 520 1.5 290 140 641 453 43 9 256 51 N 4, 44 4
IV-3 1,530 770 270 2.8 190 160 435 428 30 11 266 164 N N N N
IV-13 1,890 630 720 0.9 460 50 672 757 34 23 238 124 N 44 44 N
IV-4 1,520 650 370 1.8 130 210 757 757 76 28 225 341 N N N N
III-7C 1,160 420 270 1.6 210 120 626 407 18 20 260 78 N 4 4 N
III-13 1,040 420 350 1.2 250 90 658 132 40 25 142 91 N 44 44 N
Secondary relatives
III-1S 2,000 510 690 0.7 270 180 825 757 61 24 345 125 4 44 44 N
Spouse controls
III-10 2,090 820 860 1.0 280 170 909 280 76 257 388 63 N N 4 N
III-4 1,610 610 410 1.5 200 90 723 326 81 11 462 268 N N N N
III-14 1,080 500 300 1.7 130 130 791 897 40 11 110 56 N N 4 N
111-8 1,180 680 150 4.7 120 80 757 208 66 27 247 131 l l l N
aTested during chemotherapy; bIn remission 4 years post-chemotherapy; cObligate gene carrier; developed lymphoma in course of study. N,
normal; 4, slightly below normal range; 44, markedly below normal range (less than half of lower limit); ND, not done.
marrow-suppressive effects of ongoing chemotherapy or her
lymphoma. This patient's mitogen responses and IgM and
IgG3 levels may have been depressed for the same reason.
Significant depressions in the IgG3 levels, and response to
pokeweed mitogen and concanavalin A were present in the
ten first degree relatives. The mean IgG3 level in the group
was 37.8+17.7mgdl-P, which is significantly different from
that of the four spouse controls (61.6+17.3mgdl-1,
P<0.03). In four of these ten the IgG3 levels were below the
normal range, and in two the level was borderline low. In
two of these six that were tested there was also a significant
decrease in the responses to both pokeweed and
concanavalin A mitogen stimulation, to levels less than half
of the lower normal limit. An additional first degree relative
(IV-7) had a significantly decreased response to both
pokeweed mitogen and concanavalin A stimulation, as did
the second degree relative (111-15).
Except for a mild depression in one first degree relative,
natural killer cell function was normal in the remaining
subjects. Tests for the presence of Coombs antibody,
rheumatoid factor, antinuclear antibodies and Epstein-Barr
virus antibodies were within normal range for all of the
subjects and are not entered into Table II. HLA genotypes
in this family did not support any shared association of the
same haplotype.
Discussion
Familial lymphoma is rare and its incidence remains elusive.
Limited knowledge on the subject is due in part to the
general inattention that is frequently given to the family
history of cancer. This is unfortunate since family studies
may provide a powerful tool for comprehending cancer
aetiology and pathogenesis.
Haim et al. (1982) evaluated the statistical significance of
familial lymphoma among first degree relatives of a series of
lymphoma patients. They found a slight excess of immediate
relatives with HD in a series of 1983 HD patients. However,
they did not observe any excess of immediate relatives with
NHL in a series of 532 NHL patients.
In an extensive literature review of familial NHL, Greene
(1982) identified 38 multiple-case families with a total of 111
members with NHL, for an average of three cases per
family. About three-quarters were sib pairs representing
either sibs alone (63%, which included one pair of
monozygous twins) or sibs inclusive of other relatives (13%
of the sample). High risk kindreds have shown two major
subdivisions (Clark et al., 1987): (a) predominantly male pre-
adolescent sibships showing extranodal B-cell NHL with
gastrointestinal tract predominance; and (b) sibships with
adult onset nodal lymphomas, with an excess of affected
women. The family reported here falls into the second
category.
In our family, the transmittance of the lymphoma (Figure
1) is consistent with an autosomal dominant mode of
inheritance. This was suggested even in the initial absence of
lymphoma expression in III-7, since her daughter in
generation IV had already expressed lymphoma. This would
make 111-7 an obligate gene carrier. Tragically, this
individual indeed developed lymphoma, six months after we
counselled her that her risk of developing lymphoma at some
point approached 100%. In this context, it is interesting to
note that certain disease states associated with increased risk
of lymphomagenesis, such as the syndrome characterised by
sarcoma, breast cancer and brain tumours, lung cancer,
lymphoma, leukaemia and adrenal cortical carcinoma (SBLA
syndrome) (Lynch et al., 1978) and systemic lupus
erythmatosis, are inherited in an autosomal dominant
manner (Lynch & Schuelke, 1982; Reveille et al., 1983).
Other disease states showing an autosomal recessive
transmission, i.e. familial microcephaly syndrome
(Seemanova et al., 1985), ataxia telangiectasia, Bloom's
Syndrome, Chediak-Higashi syndrome and common variable
immunodeficiency (Lynch & Schuelke, 1982), tend to be
associated with lymphomas with pre-adolescent ages of
onset. X-linked lymphoproliferative syndrome, which is sex-
linked recessive, features extranodal lymphomas of mainly
small bowel in pre-adolescent males (Purtilo et al., 1982).
At least four of the seven lymphomas in our kindred were
of B-cell lineage. We have immunophenotyped two of the
lymphomas with antibodies against B-cell-restricted or
associated antigens, and each displayed monoclonal surfaceLYMPHOMA FAMILY 625
immunoglobulin. An additional two histologically had a
follicular architecture at low magnification, which is
morphological evidence of B-cell (follicular centre cell)
origin. The three remaining lymphomas did not have an
excess of arborising vessels, predominantly convoluted nuclei
or a pleomorphic inflammatory cell infiltrate, which may be
seen in some post-thymic T-cell lymphomas (Jaffe, 1985).
HD and NHL are generally considered to be different
diseases, and while the cells of origin of NHL can be traced
almost exclusively to B or T lymphocyte phenotypes, the
origin of the Reed-Stemnberg cell of HD is unclear (Jaffe,
1985; Foon & Todd, 1985). In this context, it is interesting
to note that one of the lymphomas in our kindred was HD,
while the other six were NHL. While the occurrence of these
two types may have been coincidental, HD and NHL have
been noted simultaneously in other lymphoma families as
well (Fraumeni et al., 1975; Buehler et al., 1975; Bjerrum et
al., 1986). Such simultaneous expression may suggest
similarities and common mechanisms of lymphomagenesis in
these two diseases.
Similarly, the occurrence of an adenocarcinoma of the
oesophageal-gastric junction in a brother of our lymphoma-
affected female sibship may be coincidental or may imply a
common genetic mechanism. An excess of carcinomas was
described in the lymphoma family of Potolsky et al. (1971),
and in the sibship of three adult females with NHL reported
by Clark et al. (1987), one subsequently developed colon
cancer, a sister had metastatic squamous cell carcinoma, the
mother had colon cancer and 13 of 22 maternal blood
relatives had various carcinomas.
One genetic mechanism that might predispose toward
multiple cancer types is a recessive cancer gene(s) that is
activated by loss of heterozygosity in transformed cells.
Recently, the recessive gene for retinoblastoma has been
found in several breast cancer cell lines (Lee et al., 1988), in
addition to some osteosarcomas and soft tissue sarcomas;
however, to date such a gene has not been found in
lymphomas.
Our family lived in an area in Nebraska which has an
incidence of NHL statistically in excess of the national
average (Weisenburger, 1985). Hoar et al. (1986) found that
an excess of NHL incidence in farmers in the neighbouring
state of Kansas was associated with herbicide use. Might
exposure to agricultural carcinogens 'unmask' a genetic
propensity to lymphomagenesis? While the 'belt' of
lymphoma counties along the Platte river in Nebraska
roughly correlates to those counties that have high herbicide
use, excess agricultural chemical use does not specifically
occur in Howard county, where St Paul is located. While a
common environmental carcinogenic exposure, acting in
concert with a putative cancer-prone genotype, is an
appropriate hypothesis to test, it was not possible for us to
perform a sufficient retrospective evaluation to enable
exclusion of potentially significant cancer causing agents.
We found subtle evidence of immunodeficiency in our
kindred, with many first and second degree relatives
manifesting decreased IgG3 levels and responses to pokeweed
and concanavalin A mitogen stimulation. Laboratory or
clinical evidence for immunodeficiency has been reported in
other lymphoma families. Fraumeni et al. (1975) found
decreased responses to PHA mitogen stimulation, increased
polyclonal IgM and abnormal EBV titres in lymphoma
family relatives and concluded: 'the immunodeficient states
are probably intrinsically related to the familial susceptibility
to lymphoma'. Similarly, Clark et al. (1987) found increased
polyclonal immunoglobulins, rheumatoid factor and
abnormal EBV titres in their family relatives. We did not see
these particular changes in our kindred first degree relatives.
Potolsky et al. (1971) found that in surviving siblings there
were decreased levels of serum IgG and depressed delayed
hypersensitivity, and several sibs had isolated quantitative
immunoglobulin class abnormalities. One member with
rheumatoid arthritis developed 'lymphosarcoma',
emphasising the association between autoimmune disorders
and lymphomagenesis (Lynch & Schuelke, 1982).
The significance of IgG3 deficiency in the aetiology of
lymphoma in this family remains elusive. There is only a
paucity of data on IgG3 deficiency, and none of the studies
address solid malignancies or lymphomas. However, it is of
interest that IgG3 deficiency has been identified among 3%
of a cohort of 6,580 patients with obstructive lung disease
and recurrent infection (Oxelius et al., 1986). Of further
interest was the finding of the presence of certain Gm
allotypes namely, Glma(x), G2m- and G3m9, among a
subset of these patients with isolated IgG3 deficiency and
recurrent infections (Grubb et al., 1986). Unfortunately, we
were not able to ascertain data on allotypes among our
patients.
In summary, this lymphoma-prone family has yielded
preliminary immunological genetic findings which may be
important in understanding the aetiology of their disorders
and may one day provide clues to the interaction of familial
immunodeficiencies and carcinogenesis. It remains to be seen
whether those primary relatives with subtle immunological
aberrations will develop lymphoma.
This study was supported in part by grants from the Health Futures
Foundation.
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